Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Protein aggregates are hallmarks of neurodegenerative diseases. The protein quality control (PQC) system normally prevents proteins from misfolding and accumulation; however, proteins somehow escape this control on disease. Here we review advances in the role of PQC in protein aggregation and neurodegeneration. We focus primarily on the protein Tau, which aggregates in Alzheimer's disease (AD) and other tauopathies. We also examine recent advances in amyloid fibril structures and the process of fibril formation via phase separation, which are shedding new light on the role of PQC in protein aggregation diseases. While specific components of the quality control system appear to be altered in disease, most chaperones and degradation factors are unchanged at the cellular end stage. Advancing the understanding of quality control factors in neurodegeneration, particularly in the early stages of disease, is among the key challenges for neurodegeneration research. Copyright © 2022 Elsevier Ltd. All rights reserved.


Margreet B Koopman, Luca Ferrari, Stefan G D Rüdiger. How do protein aggregates escape quality control in neurodegeneration? Trends in neurosciences. 2022 Apr;45(4):257-271

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 35210101

View Full Text